I understand the sentiment, but remember the generics programs essentially commenced with the appointment of the current CEO (who has substantial generics experience), and the past generics landscape was far less attractive.
- Forums
- ASX - By Stock
- ACR
- Next couple of days
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.9¢

Next couple of days, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.776M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.8¢ | $448 | 23.63K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 247925 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 40000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 247925 | 0.018 |
2 | 452389 | 0.017 |
4 | 338777 | 0.016 |
6 | 1178548 | 0.015 |
3 | 420000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 40000 | 2 |
0.021 | 255157 | 2 |
0.022 | 139348 | 2 |
0.023 | 381179 | 1 |
0.024 | 239246 | 6 |
Last trade - 12.49pm 04/07/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online